Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 21, 1991 - Issue 2
43
Views
4
CrossRef citations to date
0
Altmetric
Original Article

The influence of disulfiram on acetaminophen metabolism in man

, &
Pages 243-249 | Received 16 Oct 1989, Accepted 15 Jun 1990, Published online: 27 Aug 2009

References

  • Abernathy D. R., Greenblatt D. J., Divoll M., Ameer B., Shader R. I. Differential effect of cimetidine in drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine. Journal of Pharmacology and Experimental Therapeutics 1983; 224: 508–513
  • Abernathy D. R., Greenblatt D. J., Ameer B., Shader R. I. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation. Journal of Pharmacology and Experimental Therapeutics 1985; 234: 345–349
  • Andersson S., Boström H. Effect of disulfiram on rat liver cholesterol 7α-hydroxylase. Biochemical Pharmacology 1984; 33: 2930–2932
  • Andreasen P. B., Hutters L. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver. Acta Medico Scandinavica 1979, suppl. 624: 99–105
  • Brown R. R., Manno J. E. Estrip, a basic computer program for obtaining initial polyexponential parameter estimates. Journal of Pharmaceutical Sciences 1978; 67: 1687–1691
  • Critchley J. A. J. H., Dyson E. H., Scott A. W., Jarvie D. R., Prescott L. F. Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning?. Lancet 1989; i: 1375–1376
  • DeMaster E. G., Nagasawa H. T. Disulfiram-induced acetonemia in the rat and man. Research Communications in Chemical Pathology and Pharmacology 1977; 18: 361–364
  • Forrest J. A. H., Adriaenssens P., Finlayson N. D. C., Prescott L. F. Paracetamol metabolism in chronic liver disease. European Journal of Chemical Pharmacology 1979; 15: 427–431
  • Frank N., Hadjiolov D., Bertram B., Weissler M. Effect of disulfiram on the alkylation of rat liver DNA by nitrosodiethylamine. Journal of Cancer Research and Chemical Oncology 1977; 97: 209–212
  • Galinsky R. E., Nelson E. B., Rollins D. E. Pharmacokinetic consequences and toxicologic implications of metyrapone-induced alterations of acetaminophen elimination in man. European Journal of Chemical Pharmacology 1987; 33: 391–396
  • Hinson J. A., Roberts D. W., Benson R. W., Dalhoff K., Loft S., Poulsen H. E. Regarding the mechanism of paracetamol toxicity in humans. Lancet 1990; 335: 732
  • Jørgensen L., Thomsen P. J., Poulsen H. E. Disulfiram protects against acetaminophen hepatotoxicity in rats. Pharmacology and Toxicology 1988; 62: 267–271
  • Knox J. H., Jurand J. Determination of paracetamol and its metabolites in urine by high performance liquid chromatography using reverse-phase bonded supports. Journal of Chromatography 1977; 142: 651–670
  • Loft S., Sonne J., Pilsfård H., Døssing M., Poulsen H. E. Inhibition of hepatic drug metabolism by disulfiram and cimetidine: the effect of concomitant administration. British Journal of Clinical Pharmacology 1986; 21: 75–77
  • Maddrey W. C. Hepatic effects of acetaminophen. Enhanced effects of acetaminophen. Journal of Clinical Gastroenterolngy 1987; 9: 180–185
  • Melandri M., Poulsen H. E., Ranek L., Andreasen P. B. Effect of long-term disulfiram adminstration on rat liver. Pharmacology 1980; 21: 76–80
  • Mitchell M. C., Schenker S., Speeg K. V., Jr. Selective inhibition of acetaminophen oxidation and toxicity by cimetidine and other histamine H2-receptor antagonists in vivo and in vitro in the rat and in man. Journal of Clinical Investigations 1984; 73: 282–291
  • Mitchell J. R., Thorgeirsson S. S., Potter W. Z., Jollow D. J., Kaiser H. Acetaminophen-induced hepatic injury: Protective role of glutathione in man and rationale for therapy. Clinical Pharmacology and Therapeutics 1974; 16: 676–684
  • Moldeus P. Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochemical Pharmacology 1978; 27: 2859–2863
  • Moldeus P., Gergly V. Effect of acetone on the activation of acetaminophen. Toxicology and Applied Pharmacology 1980; 53: 8–13
  • Nelson E. B., Montes M., Goldstein M. Effectiveness of metyrapone in the treatment of acetaminophen toxicity in mice. Toxicology 1980; 17: 73–81
  • O'Reilly R. A. Interaction of sodium warfarin and disulfiram (Antabuse) in man. Annals of Internal Medicine 1973; 28: 73–76
  • Poulsen H. E., Lerche A., Pedersen N. T. Phenobarbital induction does not potentiate but accelerates liver cell necrosis from acetaminophen overdose in the rat. Pharmacology 1985; 30: 100–108
  • Roberts D. W., Pumford N. R., Potter D. W., Benson R. W., Hinson J. A. A sensitive immunochemical assay for acetaminophen-protein adducts. Journal of Pharmacology and Experimental Therapeutics 1987; 241: 527–533
  • Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scandinavian Journal of Laboratory Investigation 1966; 18(Suppl. 92)118–125
  • Villeneuve J. P., Raymond G., Bruneau J., Colpron L., Pomier-Layraques G. Pharmacocinetique et metabolism de l'acetaminophene ches des sujects normaux, alcoholique et cirrhotique. Gastroenterologie Clinique et Biologique 1983; 7: 898–902

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.